Is Nutranomics, Inc. (NNRX) a Buy, Sell, or Hold?
OTC : NNRX
Nutranomics, Inc.
$5e-05 USD
$0 (0.0%)
- Volume
- 300K
- Average Volume
- 412.37K
- Market Capitalization
- $816.23K
- P/E Ratio
- -0.07
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.00
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.18
Company Overview
OTC
Jonathan Bishop
Drug Manufacturers - Specialty & Generic
Healthcare
NNRX
1
US
USD
Liquidity Metrics
-1.40
0.18
0.10
0.02
0.00
Sales & Valuation
$2.85M
0.29
-0.05
-0.14
0.00
Profitability
-$0.0007
-$6.63M
-232.89%
-232.89%
99.34%
-36.76%
P/E Metrics
-0.07
0.00
0.00
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
-2.52
3/9
-$15.62M
$17.81M
$31.89M
-$3.23M
Key Metrics (TTM)
$15.3M
5.37
-3.81
0.18
99.34%
-101.26%
-1382.78%
-728.56%
134 days
Company Executives
| Name | Title |
|---|---|
| Laura Riffel | Chief Operations Officer |
| Neil Zoller | Senior Vice President of Agricultural Supply Chain |
| Geoffrey Bazegian | President & Chief Revenue Officer |
| Jonathan Bishop | Chief Executive Officer & Member of Advisory Board |
Poll Results
No votes yet today — be the first to share your view!
About Nutranomics, Inc. (OTC:NNRX) Stock
Nutranomics, Inc. focuses on the research, development, and marketing of health-focused nutritional products. Their extensive catalog features nearly 500 distinct dietary supplements, encompassing formulations of vitamins, minerals, herbal remedies, and probiotics. Beyond its product offerings, the company provides innovative services, such as its Nutritional Blood Analysis—a diagnostic tool enabling customers to observe their blood cells live on a video monitor—and the patented Assimilation Enhancing System, which is engineered to optimize nutrient absorption. Additionally, Nutranomics delivers comprehensive educational resources, including various forms of analysis, training programs, professional certifications, and group presentations, catering to both individuals and industry experts. ... The distribution of its products occurs globally through a network of sales representatives across North America and Asia, alongside availability in retail stores. Nutranomics, Inc. also maintains a strategic alliance with Terra-Formance, LLC. Established in 1995, the company is based in Salt Lake City, Utah.
Frequently Asked Questions
-
What is the current Nutranomics, Inc. (NNRX) stock price?
-
Nutranomics, Inc.(OTC:NNRX) stock price is $5e-05 in the last trading session. During the trading session, NNRX stock reached the peak price of $0.0001 while $0.00005 was the lowest point it dropped to. The percentage change in NNRX stock occurred in the recent session was 0.0% while the dollar amount for the price change in NNRX stock was $0.
-
NNRX's industry and sector of operation?
-
The OTC listed NNRX is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
-
Who are the executives of NNRX?
-
Laura Riffel | Chief Operations Officer
Neil Zoller | Senior Vice President of Agricultural Supply Chain
Geoffrey Bazegian | President & Chief Revenue Officer
Jonathan Bishop | Chief Executive Officer & Member of Advisory Board
| -
How many employees does NNRX have?
-
Number of NNRX employees currently stands at 1. NNRX operates from 11487 South 700 East, Salt Lake City, UT 84020, US.
-
Link for NNRX official website?
-
Official Website of NNRX is: https://www.nutranomics.com
-
How do I contact NNRX?
-
NNRX could be contacted at phone #801-576-8350 and can also be accessed through its website. NNRX operates from 11487 South 700 East, Salt Lake City, UT 84020, US.
-
How many shares of NNRX are traded daily?
-
The average number of NNRX shares traded daily for last 3 months was 412.37K.
-
What is the market cap of NNRX currently?
-
The market value of NNRX currently stands at $816.23K with its latest stock price at $5e-05